Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries.
Association
Co-morbidities
Mental disorders
Meta-analysis
Neurotropic parasitic diseases
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
05 Dec 2019
05 Dec 2019
Historique:
received:
19
08
2019
accepted:
11
11
2019
entrez:
7
12
2019
pubmed:
7
12
2019
medline:
5
3
2020
Statut:
epublish
Résumé
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries. As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0. In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4-55.9). In 16 pooled studies that included 1782 people with mental disorders and 1776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7-3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7-3.4). Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.
Sections du résumé
BACKGROUND
BACKGROUND
Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between mental disorders (anxiety, depression, bipolar disorder, and schizophrenia) and neurotropic parasitic diseases (malaria, cysticercosis, toxoplasmosis, human African trypanosomiasis, Chagas disease, and human toxocariasis) in developing and emerging countries.
METHODS
METHODS
As the first meta-analysis on this topic, this study was performed in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (N°CRD42017056521). The Medline, Embase, Lilacs, and Institute of Epidemiology and Tropical Neurology databases were used to search for articles without any restriction in language or date. We evaluated the quality of studies independently by two investigators using the Downs and Black assessment grid and pooled estimates using the random-effects method from CMA (Comprehensive Meta Analysis) Version 3.0.
RESULTS
RESULTS
In total, 18 studies published between 1997 and 2016 met our inclusion criteria. We found that the prevalence of anxiety and depression in people suffering from Chagas disease and/or neurocysticercosis was 44.9% (95% CI, 34.4-55.9). In 16 pooled studies that included 1782 people with mental disorders and 1776 controls, toxoplasmosis and/or toxocariasis were associated with increased risk of schizophrenia and/or bipolar disorders (odds ratio = 2.3; 95% CI, 1.7-3.2). Finally, toxocariasis and/or toxoplasmosis were associated with an increased risk of the onset of schizophrenia (odds ratio = 2.4; 95% CI, 1.7-3.4).
CONCLUSION
CONCLUSIONS
Our pooled estimates show that the associations between diseases studied are relatively high in developing and emerging countries. This meta-analysis supports the hypothesis that toxoplasmosis could be the cause of schizophrenia. These findings could prove useful to researchers who want to further explore and understand the associations studied.
Identifiants
pubmed: 31805904
doi: 10.1186/s12889-019-7933-4
pii: 10.1186/s12889-019-7933-4
pmc: PMC6896488
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
1645Références
Metab Brain Dis. 2016 Aug;31(4):749-59
pubmed: 27041387
Handb Clin Neurol. 2013;114:217-28
pubmed: 23829912
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1829-1835
pubmed: 27502929
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
BMC Infect Dis. 2008 Jun 30;8:88
pubmed: 18590541
Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):377-8
pubmed: 7570867
Qual Life Res. 2011 Feb;20(1):133-8
pubmed: 21046258
J Affect Disord. 2017 Feb;209:59-65
pubmed: 27889597
Trop Biomed. 2012 Mar;29(1):151-9
pubmed: 22543615
Iran J Parasitol. 2011 Jun;6(2):31-7
pubmed: 22347285
Indian J Med Sci. 2010 Jul;64(7):307-14
pubmed: 22918071
PLoS Negl Trop Dis. 2014 Aug 07;8(8):e3082
pubmed: 25101756
Epidemiol Infect. 2017 May;145(7):1351-1362
pubmed: 28183362
Adv Ther. 2008 Jul;25(7):703-9
pubmed: 18563312
Acta Psychiatr Scand. 2015 Sep;132(3):161-79
pubmed: 25877655
Iran J Psychiatry Behav Sci. 2016 Aug 17;10(3):e3604
pubmed: 27826323
J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):612-6
pubmed: 9219748
BMC Public Health. 2019 Mar 13;19(1):304
pubmed: 30866883
J Chin Med Assoc. 2015 Sep;78(9):533-7
pubmed: 26233294
Semin Pediatr Neurol. 2014 Mar;21(1):19-25
pubmed: 24655400
Jundishapur J Microbiol. 2014 Nov;7(11):e12776
pubmed: 25774275
PLoS One. 2013 Apr 23;8(4):e62606
pubmed: 23626838
Southeast Asian J Trop Med Public Health. 2005 Nov;36(6):1399-406
pubmed: 16610641
Korean J Parasitol. 2002 Sep;40(3):113-7
pubmed: 12325440
Int J Soc Psychiatry. 2015 Aug;61(5):456-64
pubmed: 25300671
Rev Assoc Med Bras (1992). 2010 Mar-Apr;56(2):173-8
pubmed: 20498991
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
Yonsei Med J. 2008 Apr 30;49(2):224-9
pubmed: 18452258
Arq Neuropsiquiatr. 1998 Mar;56(1):45-52
pubmed: 9686119
Korean J Parasitol. 2015 Feb;53(1):29-34
pubmed: 25748706
J Glob Health. 2015 Dec;5(2):020406
pubmed: 26649173
J Matern Fetal Neonatal Med. 2014 Sep;27(13):1368-74
pubmed: 24156764
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
J Back Musculoskelet Rehabil. 2012;25(4):253-60
pubmed: 23220808
Acta Neurol Taiwan. 2014 Mar;23(1):1-3
pubmed: 24833208
Psychiatry Res. 2016 Nov 30;245:327-332
pubmed: 27573055
Rev Inst Med Trop Sao Paulo. 1990 May-Jun;32(3):204-10
pubmed: 2135374
Ann Soc Belg Med Trop. 1994 Jun;74(2):105-12
pubmed: 7944647
Trop Biomed. 2010 Dec;27(3):476-82
pubmed: 21399589
Rev Inst Med Trop Sao Paulo. 2016 Sep 22;58:70
pubmed: 27680175
Int J Nurs Pract. 2013 Feb;19(1):14-22
pubmed: 23432884
Schizophr Res. 2012 Apr;136(1-3):128-36
pubmed: 22104141
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Hormones (Athens). 2015 Jul-Sep;14(3):417-24
pubmed: 26188226
Rev Soc Bras Med Trop. 2007 Nov-Dec;40(6):661-4
pubmed: 18200421
Support Care Cancer. 2014 Feb;22(2):453-9
pubmed: 24091720
Korean J Parasitol. 2001 Mar;39(1):1-11
pubmed: 11301585
Neuro Endocrinol Lett. 2007 Apr;28(2):115-20
pubmed: 17435677
Schizophr Bull. 2007 May;33(3):789-91
pubmed: 17404388
Int J Biomed Sci. 2014 Dec;10(4):269-71
pubmed: 25598759
Int J Chron Obstruct Pulmon Dis. 2014 May 20;9:501-12
pubmed: 24876770
Parasitol Int. 2011 Jun;60(2):151-5
pubmed: 21292026
Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):477-82
pubmed: 24961793
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Indian J Med Res. 2014 Mar;139(3):402-8
pubmed: 24820834
Med Sante Trop. 2014 Oct-Dec;24(4):367-74
pubmed: 25296005
Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1257-68
pubmed: 23959589
J Psychosom Res. 2001 Apr;50(4):179-83
pubmed: 11369022
Int J Infect Dis. 2010 Nov;14(11):e978-81
pubmed: 20843718